These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26048710)

  • 1. Developing a framework of care for opioid medication misuse in community pharmacy.
    Cochran G; Gordon AJ; Field C; Bacci J; Dhital R; Ylioja T; Stitzer M; Kelly T; Tarter R
    Res Social Adm Pharm; 2016; 12(2):293-301. PubMed ID: 26048710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief intervention medication therapy management: Establishment of an opioid misuse intervention model delivered in a community pharmacy.
    Kenney A; Cox N; Bryan MA; Cochran G
    Am J Health Syst Pharm; 2021 Feb; 78(4):310-319. PubMed ID: 33386733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A community pharmacy intervention for opioid medication misuse: A pilot randomized clinical trial.
    Cochran G; Field C; Karp J; Seybert AL; Chen Q; Ringwald W; Hruschak V; Chickering S; Kincman J; Jaber A; Tarter R
    J Am Pharm Assoc (2003); 2018; 58(4):395-403. PubMed ID: 29691197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients.
    Riley TB; Alemagno S
    Res Social Adm Pharm; 2019 Aug; 15(8):986-991. PubMed ID: 30665825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
    Kibicho J; Owczarzak J
    AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk.
    Strand MA; Eukel H; Burck S
    Res Social Adm Pharm; 2019 Aug; 15(8):1032-1036. PubMed ID: 30031696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing opioid medication misuse at point of service in community pharmacy: A study protocol for an interdisciplinary behavioral health trial.
    Cochran G; Shen J; Cox N; Field C; Carlston K; Sengpraseut B; White A; Okifuji A; Jackman C; Haaland B; Ragsdale R; Gordon AJ; Tarter R
    Contemp Clin Trials; 2022 May; 116():106759. PubMed ID: 35417771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing inappropriate use of non-prescription combination analgesics containing codeine: A modified Delphi study.
    Gibbins AK; Wood PJ; Spark MJ
    Res Social Adm Pharm; 2017; 13(2):369-377. PubMed ID: 27084506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.
    Green TC; Case P; Fiske H; Baird J; Cabral S; Burstein D; Schwartz V; Potter N; Walley AY; Bratberg J
    J Am Pharm Assoc (2003); 2017; 57(2S):S19-S27.e4. PubMed ID: 28214219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists Who Screen and Discuss Opioid Misuse With Patients: Future Directions for Research and Practice.
    Cochran G; Field C; Lawson K
    J Pharm Pract; 2015 Aug; 28(4):404-12. PubMed ID: 24532819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' perspectives on MedSMA℞T: A serious game to educate youth about opioid safety.
    Abraham O; Slonac E; Paulsen Z
    J Am Pharm Assoc (2003); 2023; 63(4):1087-1094.e1. PubMed ID: 37116795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0).
    ;
    J Am Pharm Assoc (2003); 2008; 48(3):341-53. PubMed ID: 18595820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
    Nielsen S; Kowalski M; Wood P; Larney S; Bruno R; Shanahan M; Lenton S; Dietze P; Green T; Murnion B; Ritter A
    Res Social Adm Pharm; 2019 Aug; 15(8):1047-1055. PubMed ID: 30396825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A community pharmacy-led intervention for opioid medication misuse: A small-scale randomized clinical trial.
    Cochran G; Chen Q; Field C; Seybert AL; Hruschak V; Jaber A; Gordon AJ; Tarter R
    Drug Alcohol Depend; 2019 Dec; 205():107570. PubMed ID: 31689641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of patient-community pharmacist encounter toolkit regarding substance misuse: Delphi procedure.
    Fatani S; Bakke D; Halpape K; D'Eon M; El-Aneed A
    J Am Pharm Assoc (2003); 2022; 62(1):176-186. PubMed ID: 34538771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of comprehensive medication management at supermarket pharmacies in a pharmacy network.
    Doong K; Berenbrok LA; Coley KC; Carroll JC; Richardson R; Antinopoulos BC; Patel A; McGivney MS
    J Am Pharm Assoc (2003); 2019; 59(4S):S25-S31. PubMed ID: 31080149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical exploration of Tennessee community pharmacists' perceptions regarding opioid pain reliever abuse communication.
    Hagemeier NE; Murawski MM; Lopez NC; Alamian A; Pack RP
    Res Social Adm Pharm; 2014; 10(3):562-75. PubMed ID: 23981913
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.